| Literature DB >> 25052528 |
Amiethab Aiyer1, William Hennrikus, Jessica Walrath, Brandt Groh, Barbara Ostrov.
Abstract
BACKGROUND: Lyme arthritis can be readily treated with use of oral antibiotics without any need for surgery. In Lyme-endemic areas, differentiating between Lyme arthritis and septic arthritis can be difficult. Laboratory testing for Lyme disease often results in a delay in diagnosis because many labs batch-test Lyme specimens only two times per week due to lack of equipment or increased expense. Delayed diagnosis can lead to unneeded surgery in cases in which the surgeon indicates the patient for a joint irrigation and debridement (I & D) for possible septic arthritis while waiting for Lyme serology results. The purpose of this study was to develop an algorithm for the treatment of patients with possible Lyme arthritis, with particular attention to poly-articular involvement.Entities:
Year: 2014 PMID: 25052528 PMCID: PMC4128947 DOI: 10.1007/s11832-014-0602-3
Source DB: PubMed Journal: J Child Orthop ISSN: 1863-2521 Impact factor: 1.548
CDC definition of Lyme Disease [12]
| Clinical case definition |
| Erythema migrans, or |
| At least one advanced manifestation, as defined below, and laboratory confirmation of infection |
| Advanced Manifestations (not including CV/CNS) |
| Musculoskeletal System |
| Recurrent, brief attacks (lasting weeks or months) of objective joint swelling in one or a few joints, sometimes followed by chronic arthritis in one or a few joints |
| Manifestations not considered criteria for diagnosis include chronic progressive arthritis, not preceded by brief attacks, and chronic symmetrical polyarthritis |
| Arthralgia, myalgia, or fibromyalgia syndromes alone are not criteria for musculoskeletal involvement |
| Laboratory criteria for diagnosis |
| Positive culture for |
| Demonstration of diagnostic levels of IgM and IgG antibodies to the spirochetes in serum |
| Two-tier testing interpreted using established criteria, where: |
| Positive IgM is sufficient only when ≤30 days from system onset |
| Positive IgG is sufficient at any point during illness |
| Single tier IgG immunoblot seropositivity using established criteria, or |
| CSF antibody positive for |
Fig. 1Representative joint involvement in 155 patients with Lyme disease. The knee was most frequently involved, with the ankle second most commonly involved
Clinical presentation of 39 patients presenting with poly-articular lyme disease with ankle involvement
| Pt | Age | M/F | Joints involved | Pain with range of motion | Fever >38.5 °C | Refusal to bear weight |
|---|---|---|---|---|---|---|
| 1 | 17 | M | Ankles, knees, neck | No | No | No |
| 2 | 13 | F | L ankle | No | No | No |
| 3 | 8 | F | R ankle, R knee | Yes (R knee) | No | No |
| 4 | 7 | M | Ankles, hips | No | No | No |
| 5 | 8 | F | Ankles, L knee | No | No | No |
| 6 | 13 | M | Ankles, L knee, R wrist | No | No | No |
| 7 | 5 | M | L ankle, L knee, L hip, L knee, L shoulder | No | No | No (antalgic gait) |
| 8 | 7 | F | R ankle, knees, L hip | Yes (R ankle, knees) | No | No |
| 9 | 17 | F | Ankles, wrists | No | No | No |
| 10 | 14 | M | Ankles, knees | Yes (R ankle) | No | No (antalgic gait) |
| 11 | 12 | M | Ankles | No | No | No |
| 12 | 4 | M | L ankle, L knee | Yes (L knee) | No | No |
| 13 | 13 | M | R ankle, L knee, L wrist, neck | Yes (L knee) | No | No (antalgic gait) |
| 14 | 6 | F | Ankles, R hip | Yes (R hip, minimal) | No | Yes |
| 15 | 12 | M | Ankles, knees, back, neck, jaw | Yes (ankles) | No | No |
| 16 | 18 | F | Ankles, knees, elbows, wrists, MCPs | Yes (MCPs, R wrist, 4th and 5th toes) | No | No |
| 17 | 10 | F | Ankle, knees | Yes (L ankle, L knee) | No | No (antalgic gait) |
| 18 | 9 | M | Ankles, knees, wrists, R thumb | No | No | No |
| 19 | 8 | M | L ankle, L knee, L hip | Yes (L ankle, L knee, L hip, mild) | No | No |
| 20 | 9 | F | Ankles, knee, foot, elbows, neck | No | No | No |
| 21 | 12 | F | R ankle, R knee, R shoulder, R elbow, R wrist | Yes (R ankle, R knee, R wrist) | No | No |
| 22 | 5 | F | R ankle, R knee | No | No | No (antalgic gait) |
| 23 | 5 | M | R ankle, R knee, R hip | No | No | No (antalgic gait) |
| 24 | 10 | M | Ankle, shoulder, elbow, wrist, finger | Yes (R ankle) | No | No |
| 25 | 12 | M | L ankle, R knee, R elbow, neck | Yes (L ankle, R knee) | No | No |
| 26 | 6 | M | Ankle, R knee, R foot, elbow, wrist | Yes (R knee) | No | Yes |
| 27 | 7 | F | R ankle, knees, elbows, wrists | Yes (L shoulder, R wrist, R knee) | Yes | No |
| 28 | 2 | F | R ankle, knees, elbows | No | No | No |
| 29 | 11 | F | R ankle, R knee | Yes (R knee, mild) | No | No |
| 30 | 7 | F | L ankle, knees, L hip, L ankle | Yes (L knee) | Yes | No (antalgic gait) |
| 31 | 9 | M | Ankle, L elbow, wrists, neck | No | No | No |
| 32 | 12 | M | R ankle, R knee, L wrist | No | No | No |
| 33 | 6 | M | R ankle, R knee, hips | No | Yes | No (antalgic gait) |
| 34 | 12 | F | L ankle, knees, L midfoot | Yes (L ankle, R knee) | No | No (antalgic gait) |
| 35 | 7 | F | R ankle, R knee, R hip, R shoulder, R wrist, neck | No | No | No |
| 36 | 14 | M | L ankle, L knee, R elbow | Yes (R elbow, L knee) | No | No (antalgic gait) |
| 37 | 9 | F | Ankle, knee, shoulder, wrist | No | No | No |
| 38 | 9 | F | R ankle, R knee, R wrist, R thumb | No | No | No |
| 39 | 11 | F | Ankles, knees, elbows, L 5th finger | No | No | No |
Lyme laboratory results and treatment of 39 patients presenting with polyarticular lyme disease with ankle involvement
| Pt | Western blot (IgG) | ELISA | Antibiotic treatment |
|---|---|---|---|
| 1 | + | 3.25 | PO doxycycline |
| 2 | + | 1.65 | PO doxycycline |
| 3 | + | None | IV ceftriaxone, amoxicillin |
| 4 | + | None | Amoxicillin |
| 5 | + | None | Amoxicillin |
| 6 | + | None | Doxycycline |
| 7 | + | 5 | Amoxicillin |
| 8 | + | None | PO doxycycline |
| 9 | + | 2.25 | Cefuroxime |
| 10 | + | None | IV cefuroxime |
| 11 | + | None | PO doxycycline |
| 12 | + | None | Amoxicillin |
| 13 | + | None | PO doxycycline |
| 14 | + | None | Amoxicillin |
| 15 | + | 6 | IV ceftriaxone |
| 16 | + | None | IV ceftriaxone |
| 17 | + | 5.8 | Amoxicillin |
| 18 | + | None | PO doxycycline |
| 19 | + | None | IV ceftriaxone |
| 20 | + | 5 | Amoxicillin |
| 21 | + | 3.1 | PO doxycycline |
| 22 | + | None | Amoxicillin |
| 23 | + | None | Cefuroxamine |
| 24 | + | None | PO doxycycline |
| 25 | + | None | PO doxycycline |
| 26 | + | None | Amoxicillin |
| 27 | + | None | Amoxicillin |
| 28 | + | None | Cefuroxamine |
| 29 | + | 4.3 | PO doxycycline |
| 30 | + | None | Amoxicillin |
| 31 | + | None | PO doxycycline |
| 32 | + | None | PO doxycycline |
| 33 | + | None | Amoxicillin |
| 34 | + | 8.67 | PO doxycycline |
| 35 | + | 5.6 | Amoxicillin |
| 36 | + | None | Ceftriaxone |
| 37 | + | None | Cefuroxime |
| 38 | + | 8.2 | Amoxicillin |
| 39 | + | >5 | PO doxycycline |
Kocher criteria of 39 patients presenting with polyarticular lyme disease with ankle involvement
| Pt | Fever >38.5 °C | WBC (/mm3) | Refusal to bear weight | ESR (mm/h) | Kocher criteria |
|---|---|---|---|---|---|
| 1 | No | 10 | No | 8 | 0/4 |
| 2 | No | 12.8 | No | 25 | ¼ |
| 3 | No | 13.7 | No | 59 | 2/4 |
| 4 | No | n/a | No | 53 | 1/4 |
| 5 | No | 11.6 | No | 90 | 1/4 |
| 6 | No | WNL | No | WNL | 0/4 |
| 7 | No | n/a | No | 22 | 0/4 |
| 8 | No | 5 | No | 17 | 0/4 |
| 9 | No | 5.6 | No | 90 | 1/4 |
| 10 | No | 4.6 | No | 2 | 0/4 |
| 11 | No | n/a | No | n/a | 0/4 |
| 12 | No | 11 | No | 45 | 1/4 |
| 13 | No | WNL | No | WNL | 0/4 |
| 14 | No | 12.6 | Yes | 90 | 3/4 |
| 15 | No | 6.61 | No | n/a | 0/4 |
| 16 | No | WNL | No | n/a | 0/4 |
| 17 | No | WNL | No | 44 | 1/4 |
| 18 | No | 6.6 | No | 15 | 0/4 |
| 19 | No | 13 | No | 36 | 1/4 |
| 20 | No | 7.6 | No | 12 | 0/4 |
| 21 | No | WNL | No | 28 | 0/4 |
| 22 | No | 15.5 | No | 75 | 2/4 |
| 23 | No | n/a | No | n/a | 0/4 |
| 24 | No | n/a | No | n/a | 0/4 |
| 25 | No | 9 | No | 50 | 1/4 |
| 26 | No | 3.5 | Yes | 15 | 1/4 |
| 27 | Yes | 16.3 | No | 65 | 3/4 |
| 28 | No | 14.1 | No | 53 | 2/4 |
| 29 | No | 10.7 | No | 50 | 1/4 |
| 30 | Yes | 13.9 | No | 81 | 3/4 |
| 31 | No | n/a | No | 33 | 0/4 |
| 32 | No | n/a | No | n/a | 0/4 |
| 33 | Yes | 14.6 | No | 45 | 3/4 |
| 34 | No | 11.3 | No | 30 | 0/4 |
| 35 | No | 13.8 | No | 54 | 2/4 |
| 36 | No | 8.3 | No | 22 | 0/4 |
| 37 | No | 8 | No | 4 | 0/4 |
| 38 | No | 4.6 | No | 32 | 0/4 |
| 39 | No | 7.2 | No | n/a | 0/4 |